Peer Review reports
From: Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer
Original Submission | ||
---|---|---|
6 May 2022 | Submitted | Original manuscript |
12 Jun 2022 | Reviewed | Reviewer Report |
14 Jul 2022 | Reviewed | Reviewer Report |
2 Sep 2022 | Reviewed | Reviewer Report |
20 Sep 2022 | Author responded | Author comments - Qiu Li |
Resubmission - Version 2 | ||
20 Sep 2022 | Submitted | Manuscript version 2 |
20 Sep 2022 | Reviewed | Reviewer Report |
20 Sep 2022 | Reviewed | Reviewer Report |
1 Oct 2022 | Reviewed | Reviewer Report |
6 Oct 2022 | Author responded | Author comments - Qiu Li |
Resubmission - Version 3 | ||
6 Oct 2022 | Submitted | Manuscript version 3 |
10 Oct 2022 | Reviewed | Reviewer Report |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
11 Oct 2022 | Editorially accepted | |
19 Oct 2022 | Article published | 10.1186/s12859-022-04984-5 |
You can find further information about peer review here.